Through long-term investment in quality systems and regulatory frameworks, ADSS has built comprehensive compliance capabilities aligned with international medical device standards, supporting sustainable global market expansion.

ADSS has achieved China’s first EU MDR dual certification, covering both picosecond laser and CO₂ fractional laser systems, including approvals for medical and non-medical applications. This milestone represents a breakthrough for China’s optoelectronic industry under the EU’s highest regulatory framework and highlights ADSS’s leadership in medical-grade quality, technological strength, and global regulatory compliance.

Over nearly two decades of development, ADSS has established a fully integrated and independent R&D and manufacturing system, forming a solid foundation for scalable innovation and long-term technological leadership in medical aesthetic devices.

ADSS Group successfully organized a three-day team building trip at Yesanpo Baili Canyon, combining a mid-year strategic review with its 18th anniversary celebration. Strategic reflection, outdoor challenges, and immersive team activities strengthened cross-team collaboration, reinforced shared values, and further united the ADSS team toward sustainable growth.

Through strategic collaboration with Peking Union Medical College Hospital, ADSS integrates clinical insight into engineering development, advancing evidence-based innovation in medical aesthetic devices.

ADSS Group convened its Quarterly Summary Meeting from June 26–28, 2021, gathering leadership and over 300 staff to review achievements, discuss challenges, and outline strategic plans for the remainder of the year, coinciding with the 100th anniversary of the founding of the Communist Party of China.